RIGEL PHARMACEUTICALS, INC. 13G

Company

RIGEL PHARMACEUTICALS INC

Filed

March 23, 2005

Accession Number

0000935069-05-000667

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →